Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

10x Genomics (TXG) Assets Average (2019 - 2026)

10x Genomics' Assets Average history spans 7 years, with the latest figure at $1.0 billion for Q4 2025.

  • On a quarterly basis, Assets Average rose 11.44% to $1.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.0 billion, a 11.44% increase, with the full-year FY2025 number at $980.0 million, up 4.05% from a year prior.
  • Assets Average hit $1.0 billion in Q4 2025 for 10x Genomics, up from $1.0 billion in the prior quarter.
  • Over the last five years, Assets Average for TXG hit a ceiling of $1.0 billion in Q4 2025 and a floor of $911.0 million in Q1 2025.
  • Historically, Assets Average has averaged $974.7 million across 5 years, with a median of $976.6 million in 2021.
  • Biggest five-year swings in Assets Average: soared 61.89% in 2021 and later fell 7.58% in 2024.
  • Tracing TXG's Assets Average over 5 years: stood at $1.0 billion in 2021, then rose by 0.79% to $1.0 billion in 2022, then decreased by 5.51% to $956.8 million in 2023, then dropped by 2.99% to $928.2 million in 2024, then rose by 11.44% to $1.0 billion in 2025.
  • Business Quant data shows Assets Average for TXG at $1.0 billion in Q4 2025, $1.0 billion in Q3 2025, and $941.7 million in Q2 2025.